Citation Impact
Citing Papers
Epigenetic Repression of DNA Mismatch Repair by Inflammation and Hypoxia in Inflammatory Bowel Disease–Associated Colorectal Cancer
2009 StandoutNobel
MutL traps MutS at a DNA mismatch
2015 StandoutNobel
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
An Msh2 Point Mutation Uncouples DNA Mismatch Repair and Apoptosis
2004
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop
1999 Standout
Human Mismatch Repair
2005 StandoutNobel
DNA Mismatch Repair-dependent Activation of c-Abl/p73α/GADD45α-mediated Apoptosis
2008
Work ability and return-to-work in cancer patients
2008
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
2009
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
2005 StandoutNature
The Saccharomyces cerevisiae Msh2 Mismatch Repair Protein Localizes to Recombination Intermediates In Vivo
2000
Inhaled Corticosteroids
2003
Microsatellite Instability in Colorectal Cancer
2010 Standout
Human genetic defects in class-switch recombination (hyper-IgM syndromes)
2001 StandoutNobel
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
Mutations in the nucleotide-binding domain of MutS homologs uncouple cell death from cell survival
2004
Differential and Simultaneous Adenosine Di- and Triphosphate Binding by MutS
2003 StandoutNobel
EPIDEMIOLOGY OF THE VASCULITIDES
2001
Update on glucocorticoid action and resistance
2006
Direct Visualization of Asymmetric Adenine Nucleotide-Induced Conformational Changes in MutLα
2008 StandoutNobel
Albumin–drug interaction and its clinical implication
2013 Standout
Interactions of Human Mismatch Repair Proteins MutSα and MutLα with Proteins of the ATR-Chk1 Pathway
2009 StandoutNobel
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
Assembly and Molecular Activities of the MutS Tetramer
2003 StandoutNobel
HIF-1α Induces Genetic Instability by Transcriptionally Downregulating MutSα Expression
2005 StandoutNobel
Activation of Human MutS Homologs by 8-Oxo-guanine DNA Damage
2002
Methylation-induced G2/M arrest requires a full complement of the mismatch repair protein hMLH1
2003
Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study
2015 Standout
Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma
2007
Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility
2004
The mismatch repair system is required for S-phase checkpoint activation
2002
Human Exonuclease I Is Required for 5′ and 3′ Mismatch Repair
2002 StandoutNobel
Structure of the Human MutSα DNA Lesion Recognition Complex
2007 StandoutNobel
Novel Roles for MLH3 Deficiency and TLE6-Like Amplification in DNA Mismatch Repair-Deficient Gastrointestinal Tumorigenesis and Progression
2008 StandoutNobel
Defects in homologous recombination repair in mismatch-repair-deficient tumour cell lines
2002
Cellular processing of platinum anticancer drugs
2005 Standout
Circadian control of the immune system
2013 Standout
Use of Corticosteroids in Treating Infectious Diseases
2008
DNA mismatch repair defects: role in colorectal carcinogenesis
2002
Structure and function of mismatch repair proteins
2000
Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis
2006
The mismatch DNA repair heterodimer, hMSH2/6, regulates BLM helicase
2004 StandoutNobel
Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies
2002
The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome
2013
Return-to-work interventions integrated into cancer care: a systematic review
2010 Standout
Functional interactions and signaling properties of mammalian DNA mismatch repair proteins
2001
Differential Specificities and Simultaneous Occupancy of Human MutSα Nucleotide Binding Sites
2004 StandoutNobel
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
CURCUMIN: THE INDIAN SOLID GOLD
2007 Standout
Cancer as an evolutionary and ecological process
2006 Standout
Reduced apoptotic response to camptothecin in CHO cells deficient in XRCC3
2003
Polymyositis and dermatomyositis
2003 Standout
A Defined Human System That Supports Bidirectional Mismatch-Provoked Excision
2004 StandoutNobel
Pathological assessment of mismatch repair gene variants in Lynch syndrome: Past, present, and future
2012
Mechanism of 5′-Directed Excision in Human Mismatch Repair
2003 StandoutNobel
Mammalian DNA mismatch repair protects cells from UVB-induced DNA damage by facilitating apoptosis and p53 activation
2003
Topoisomerase I inhibitors: camptothecins and beyond
2006 Standout
DNA Chain Length Dependence of Formation and Dynamics of hMutSα·hMutLα·Heteroduplex Complexes
2001 StandoutNobel
Integrating cell-signalling pathways with NF-κB and IKK function
2006 Standout
Involvement of the β Clamp in Methyl-directed Mismatch Repair in Vitro
2009 StandoutNobel
The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis.
2001
Vasculopathy of the Antiphospholipid Syndromes Revisited: Thrombosis is the Culprit and Vasculitis the Consort
1996
Mammalian DNA Mismatch Repair
1999
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors.
2002
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
2001
British Guideline on the Management of Asthma
2008
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
Oxidative DNA damage: mechanisms, mutation, and disease
2003 Standout
Warfarin plus Aspirin after Myocardial Infarction or the Acute Coronary Syndrome: Meta-Analysis with Estimates of Risk and Benefit
2005
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
The effect of curcumin on mismatch repair (MMR) proteins hMSH2 and hMLH1 after ultraviolet (UV) irradiation on HL-60 cells
2003
Functional specificity of MutL homologs in yeast: Evidence for three Mlh1-based heterocomplexes with distinct roles during meiosis in recombination and mismatch correction
1999
Roles for Mismatch Repair Factors in Regulating Genetic Recombination
2000
Complementation of an hMSH2 defect in human colorectal carcinoma cells by human chromosome 2 transfer
2000
High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6
2001 StandoutNobel
Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin
2003
Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation
2004 Standout
Works of Mark Lloyd being referenced
ALLERGIC DISORDERS IN SYSTEMIC VASCULITIS: A CASE-CONTROLLED STUDY
1994
The self‐regulatory model in women with rheumatoid arthritis: Relationships between illness representations, coping strategies, and illness outcome
2005
Ciclesonide, a Novel Inhaled Steroid, Does Not Affect Hypothalamic-Pituitary-Adrenal Axis Function in Patients With Moderate-to-Severe Persistent Asthma
2005
Philip Showalter Hench, 1896-1965
2002
High doses of the novel inhaled steroid ciclesonide have no effect on HPA-axis function in patients with moderate-to-severe persistent asthma
2003
Prevalence and clinical significance of subungual splinter haemorrhages in patients with the antiphospholipid syndrome.
1995
Apoptosis induced by overexpression of hMSH2 or hMLH1.
1999
Primary antiphospholipid syndrome evolving into systemic lupus erythematosus.
1995
Racial variation in serum creatine kinase levels
1996